| Optometric Providers Inc | |
|
751 Providence Highway, Dedham, MA 02026 | |
| (781) 329-0531 | |
| (781) 320-0503 |
| Full Name | Optometric Providers Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 751 Providence Highway, Dedham, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710936034 | NPI | - | NPPES |
| 9781048 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Optometric Providers Inc 2921 Erie Blvd East, Optometric Providers Inc, Syracuse, NY 13224 Ph: (315) 446-3145 | Optometric Providers Inc 751 Providence Highway, Dedham, MA 02026 Ph: (781) 329-0531 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered additional commentary, clarifications and insights on yesterday's announcement of its Phase IIa clinical results of Serdaxin® in the treatment of major depressive disorder (MDD).
Prospect Medical Holdings, Inc., announced today that it has extended until 5:00 p.m. New York City time, on December 3, 2009, its pending offer to exchange (the "Exchange Offer") up to $160,000,000 of its 12¾% Senior Secured Notes, Series B, due 2014 (the "Exchange Notes"), which have been registered under the Securities Act of 1933, as amended, for an equal amount of its privately placed 12¾% Senior Secured Notes, Series A, due 2014 (the "Private Notes").
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
Researchers from the Imperial College Faculty of Medicine in London in the United Kingdom revealed that the presence and size of a juxtaluminal black (hypoechoic) area (JBA) on carotid ultrasound of asymptomatic carotid artery plaques can predict the occurrence of ipsilateral ischemic stroke.
› Verified 1 days ago
Dedham Ophthalmic Consultants And Surgeons Pc Optometrist Medicare: Medicare Enrolled Practice Location: 980 Washington St, Suite 120, Dedham, MA 02026 Phone: 781-251-2222 Fax: 781-234-0279 | |
Lickteig Family Eyecare Pc Optometrist Medicare: Medicare Enrolled Practice Location: 870 Providence Hwy, Dedham, MA 02026 Phone: 781-329-0067 Fax: 781-320-5603 | |
Helen Farjad Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9211 Station Cir, Dedham, MA 02026 Phone: 781-329-4514 Fax: 508-484-2008 | |
Christine Minh Tran, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 870 Providence Hwy, Dedham, MA 02026 Phone: 781-329-0067 | |
Dedham Medical Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Lyons St, Dedham, MA 02026 Phone: 781-329-1400 | |
Dr. Michael Robert Adams, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 870 Providence Hwy, Attn: Dr. Adams, Dedham, MA 02026 Phone: 781-329-0067 Fax: 781-320-5603 | |
Erin Elizabeth Lord, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 870 Providence Hwy, Dedham, MA 02026 Phone: 781-329-0067 Fax: 781-320-5603 |